Revealed: Chris Rabb Has Longtime Relationship With Organizers of Antisemitic Boycott He Won’t Condemn, Joined Them in Effort To Free Cop-Killer Mumia Abu-Jamal
Rabb, the far-left congressman-elect in Philadelphia, is refusing to comment on an ugly boycott of Jewish businesses in his district on the anniversary of Kristallnacht
‘Shut It Down’ Effort Accelerates at Harvard as Second Union Joins Strike
One undergraduate had seven classes canceled, a parent says
ANALYSIS: Abdul El-Sayed Comes Up Short on Capitol Hill
Unearthed photos spark fresh concerns as Democrats celebrate
'We Pushed Them Into a Fight': Congressman-Elect Adam Hamawy Refuses To Call Iran a US Adversary
The Democrat will soon represent New Jersey in the House after testifying on behalf of the terror mastermind known as the Blind Sheikh
Hezbollah Mouthpiece in Lebanon Lashes Out at Free Beacon Over Report That Led to US Expelling Diplomat Who Celebrated Deadly Marine Barracks Bombing
Ibrahim Charara was sent packing on Sunday over social media comments that glorified Hezbollah and denigrated American troops
Wes Moore Lied About Leading Soldiers in Combat, His Commanding Officer Says
‘That’s not truthful,’ retired Lt. Col. James A. Gottschling says of Moore’s direct combat claims
Harvard Strike Escalates With Library Protest as Socialists, Foreigners Force Classes to Halt
'We are working against the oppressive capitalist system in its many forms'
WaPo Triumphs After Yearlong Struggle To Remove Karen Attiah From Masthead
Surprising no one, radical beefcake columnist declines to return to old job because she 'didn't feel safe'
El-Sayed 2.0? Soros Fellow Who Penned Pro-Terror Op-Eds and Advises Hamas-Tied Charity Launches Pennsylvania Senate Bid, Challenging Fetterman
Gaza-born Ahmed Moor said of Hamas's Oct. 7 terror attack: 'the natives have broken free—good for them'
Abdul El-Sayed Taps Former Big Pharma Lobbyist To Lead Senate Transition After Campaigning as a Crusader Against Big Pharma: Pick Is Fiercely Anti-Israel
Brenda Abdelall's past clients include Bayer Pharmaceuticals, which is notorious for its efforts to maximize profits for its diabetes drugs